
Wednesday, February 06, 2019—Poor sleep is a symptom of Alzheimer’s disease (AD) that worsens as the disease progresses and is also suggested to be an early symptom of AD. It has been known for some…
Thursday, January 24, 2019—In a phase 1 safety study, healthy adult volunteers, mean age 58.5 (age range 23-78 years), who took lemborexant (Eisai, Woodcliff Lake, NJ and Purdue, Stamford, CT) at b…
Wednesday, January 16, 2019—A new drug application (NDA) has been filed with the Food and Drug Administration (FDA) for lemborexant (Eisei, Woodcliff Lake, NJ and Purdue Pharma, Stamford, CT). Lemborexan…
Tuesday, January 08, 2019—The Food and Drug Administration (FDA) has granted 510(k) clearance for a wearable smartband device (Embrace; Empatica, Boston, MA) to detect seizure activity in children age …
Thursday, January 03, 2019—Noting that only 1 state, Nevada, has adopted legislation requiring use of medically accepted guidelines for determining brain death, the American Academy of Neurology (AAN) i…
January 2019—When should neuropsychologic tests be ordered and what questions should testing answer?
Wednesday, December 26, 2018—A study published in Neurology online found that taking antidepressants for depression or having anxiety or post-traumatic stress disorder (PTSD) are correlated with…
Monday, December 17, 2018—A new study published in Circulation reveals that African-Americans with moderate or severe sleep apnea are twice as likely to have hard-to-control high blood pressu…
For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com
Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.
We use cookies to offer a better user experience and to analyze site traffic. To comply with the European General Data Protection Regulation (GDPR), we are implementing a cookie consent manager to provide residents of the EU/EEA with the ability to customize their cookies. Until this is available, your continued use of this site will be deemed as consent to use of cookies.
Continue »